Iovance Biotherapeutics

Iovance Biotherapeutics
Partner Level
Visit Site

Company Overview

About Iovance Biotherapeutics

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.


AMTAGVI Patient Brochure

Downloadable Resources

© 2021 FLASCO | Premium Website Design by The HDG